phase i/ii results: first-line nalirifox in patients with pancreatic ductal adenocarcinoma
Published 3 years ago • 126 plays • Length 4:36Download video MP4
Download video MP3
Similar videos
-
0:54
napoli-3: first-line nalirifox in metastatic pancreatic ductal adenocarcinoma
-
0:40
1l nalirifox in advanced or metastatic pdac
-
6:20
first-line nalirifox shows improvement in os and pfs in metastatic pancreatic cancer
-
8:07
phase 1/2 study results of liposomal irinotecan and folfox in pancreatic cancer
-
0:52
neo-nal-iri: liposomal irinotecan 5-fu & oxaliplatin in panceratic cancer
-
0:58
dr. wang-gillam on results of a phase 1 study with defactinib in pancreatic ductal adenocarcinoma
-
0:39
phase i/ii study of adapt-001 plus an ici for patients with immune refractory cancers
-
3:05
dr. drilon discusses the results of the phase i/ii libretto-001 trial
-
3:16
synthesis, preclinical analysis, and first-inhuman phase i imaging of 89zr-dfodaratumumab for cd...
-
3:25
modular phase i/ii clinical trial evaluating the selective met-kinase inhibitor omo-1 in patient...
-
1:43
liposomal irinotecan fluorouracil/leucovorin after progression in mpdac
-
1:24
multifocal intraductal mucinous neoplasms (ipmn)
-
2:56
eileen o'reilly, md, on the phase 2 study comparing chemo with or without veliparib in pancreas
-
3:54
impact of second-line approval of liposomal irinotecan
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
5:29
first- and second-line treatments for locally advanced renal cell carcinoma
-
1:58
dr. tolaney on presence of pik3ca and esr1 mutations in monarch 2 trial in breast cancer
-
3:27
pancreatic mass neuroendocrine tumor 1 - dr. anand sahai md
-
1:10
multicenter phase ii trial evaluates adapt-001 for resistant tumors, showing promising efficacy